600216: Zhejiang Medicine Co., Ltd. - Summary | Jitta

Zhejiang Medicine Co., Ltd.

CHN:600216

Price
CN¥11.71
Loss Chance
46.2%
4.81JITTA SCORE
21.52%Over Jitta Line
Jitta Ranking
318 / 486
3,212 / 5,271
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (20)
Recent Business Performance (43)
Financial Strength (86)
Return to Shareholders (26)
Competitive Advantage (41)
Jitta Signs
Revenue and EarningConsistent
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing
Operating MarginDeclined
Recent Business PerformanceEarning decline 35.15% in the last quarter (yoy)
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.81
21.52%
4.41
> 1,000%
4.23
> 1,000%
Pharmaceuticals
7.60
0.42%
5.63
26.59%
7.34
37.52%
COMPANY DESCRIPTION
Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceuticals products in China and internationally. The company offers synthetic vitamin E, vitamin A, natural vitamin E, ß-carotene, canthaxanthin, vancomycin hydrochloride, teicoplanin, and daptomycin. It also provides fat-soluble vitamins, quinolone antibiotics, anti-drug-resistant antibiotics, and other products, as well as animal nutrition products. In addition, the company offers injectable levofloxacin lactate, vancomycin hydrochloride injection, and injectable teicoplanin products. The company was incorporated in 1997 and is headquartered in Shaoxing, China.